Clinical Trials Directory

Trials / Completed

CompletedNCT03691142

Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT)

A Retrospective Study of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT)

Status
Completed
Phase
Study type
Observational
Enrollment
207 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hereditary Haemorrhagic Telangiectasia (HHT) is a rare inherited genetic disease of autosomal dominant inheritance with a prevalence of about 1/5000. It is manifested by haemorrhage, mucocutaneous telangiectasia and visceral arteriovenous malformations (AVMs) (lung, liver and nervous system). Severe complications during pregnancy in HHT are rare but considered high risk. Intracranial or pulmonary haemorrhage, stroke and heart failure have been reported in some women with HHT during pregnancy. These complications occur most often in the second and third trimesters when maternal physiological changes such as peripheral vasodilatation and increased cardiac output are at their peak. Previous retrospective studies were conducted with numbers ranging from 40 to 97 patients and highlighted the importance of early screening of complications and specific management. The aim of this study is to describe, on a larger number of patients, the obstetric and neonatal complications in patients with HHT and followed in the French Reference Center for HHT.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireInterview of women with Hereditary Haemorrhagic Telangiectasia (HHT) during a consultation in the Reference Center for HHT or through a phone questionnaire about obstetric history, complications during pregnancy, delivery and neonatal outcomes.

Timeline

Start date
2018-10-02
Primary completion
2019-10-02
Completion
2019-10-02
First posted
2018-10-01
Last updated
2019-10-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03691142. Inclusion in this directory is not an endorsement.